International Ophthalmology

, Volume 36, Issue 4, pp 569–575 | Cite as

Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD)

Drusen subdomains in fibulin-5 AMD
  • Murat Kucukevcilioglu
  • Chetankumar B. Patel
  • Edwin M. Stone
  • Stephen R. Russell
Original Paper


To evaluate whether drusen of subjects with fibulin-5 mutation-associated age-related macular degeneration (AMD) have clinically demonstrable drusen domains as evidenced by differences between color and fluorescein angiographic profiles. Of seven patients we identified with AMD due to mutations in the fibulin-5 gene (Fib-5 AMD), five had color fundus photography and fluorescein angiography (FA). One had bilateral choroidal neovascularization and no drusen. For each eye, the green channel (GC) of the digital RGB (Red–Green–Blue) color image and hyperfluorescent domain (HD) intensity of the FA image were registered and drusen were manually segmented and measured. Totally 75 small (≤62 μm), 110 intermediate (63–125 μm), and 30 large (>125 μm) drusen were measured in four patients within the 6 × 6 mm central macular areas. All four subjects demonstrated central or paracentral HDs within each drusen perimeter. HDs were found in association with each druse, with a HD/GC ratio of 0.82, 0.76, and 0.72 respectively for small, intermediate, and large drusen (Student T Test: P < 0.01, P < 0.01, P < 0.01). A statistical difference was found for the HD/GC ratios between small- and intermediate-sized drusen and small- and large-sized drusen but not between intermediate-sized and large-sized drusen (P = 0.001, P < 0.001, P > 0.05, respectively). AMD patients with mutations in fibulin-5 share drusen phenotypic structure and have HD/GC ratios that are similar to individuals with cuticular or basal laminar drusen. Drusen substructure may reflect similarities in drusen stage and/or genesis and appear to vary among AMD genotypes.


Age-related macular degeneration Drusen Fibulin 5 Fluorescein angiography Fundus photography 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA et al (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351(4):346–353CrossRefPubMedGoogle Scholar
  2. 2.
    Russell SR, Gupta RR, Folk JC, Mullins RF, Hageman GS (2004) Comparison of color to fluorescein angiographic images from patients with early-adult onset grouped drusen suggests drusen substructure. Am J Ophthalmol 137(5):924–930CrossRefPubMedGoogle Scholar
  3. 3.
    Russell SR, Mullins RF, Schneider BL, Hageman GS (2000) Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol 129(2):205–214CrossRefPubMedGoogle Scholar
  4. 4.
    Wolfe DR (1986) Fluorescein angiography basic science and engineering. Ophthalmology 93(12):1617–1620CrossRefPubMedGoogle Scholar
  5. 5.
    Pauleikhoff D, Zuels S, Sheraidah GS, Marshall J, Wessing A, Bird AC (1992) Correlation between biochemical composition and fluorescein binding of deposits in Bruch’s membrane. Ophthalmology 99(10):1548–1553CrossRefPubMedGoogle Scholar
  6. 6.
    Bird AC, Marshall J (1986) Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K 105(Pt 6):674–682PubMedGoogle Scholar
  7. 7.
    Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC (1990) Drusen as risk factors in age-related macular disease. Am J Ophthalmol 109(1):38–43CrossRefPubMedGoogle Scholar
  8. 8.
    Haimovici R, Gantz DL, Rumelt S, Freddo TF, Small DM (2001) The lipid composition of drusen, Bruch’s membrane, and sclera by hot stage polarizing light microscopy. Invest Ophthalmol Vis Sci 42(7):1592–1599PubMedGoogle Scholar
  9. 9.
    Li CM, Clark ME, Rudolf M, Curcio CA (2007) Distribution and composition of esterified and unesterified cholesterol in extra-macular drusen. Exp Eye Res 85(2):192–201CrossRefPubMedGoogle Scholar
  10. 10.
    Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA et al (2010) Abundant lipid and protein components of drusen. PLoS ONE 5(4):e10329CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS (2005) Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res 81(6):731–741CrossRefPubMedGoogle Scholar
  12. 12.
    Rudolf M, Seckerdieck K, Grisanti S, Curcio CA (2014) Internal structure consistent with remodelling in very small drusen, revealed by filipin histochemistry for esterified cholesterol. Br J Ophthalmol 98(5):698–702CrossRefPubMedGoogle Scholar
  13. 13.
    Friedman D, Parker JS, Kimble JA, Delori FC, McGwin G Jr, Curcio CA (2012) Quantification of fluorescein-stained drusen associated with age-related macular degeneration. Retina 32(1):19–24CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Khanifar AA, Koreishi AF, Izatt JA, Toth CA (2008) Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 115(11):1883–1890CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Schlanitz FG, Sacu S, Baumann B, Bolz M, Platzer M, Pircher M et al (2015) Identification of drusen characteristics in age-related macular degeneration by polarization-sensitive optical coherence tomography. Am J Ophthalmol 160(2):335–344CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11(7):36–42Google Scholar
  17. 17.
    Curcio CA, Millican CL, Bailey T, Kruth HS (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42(1):265–274PubMedGoogle Scholar
  18. 18.
    Nakamura T, Lozano P, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S et al (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415(6868):171–175CrossRefPubMedGoogle Scholar
  19. 19.
    Yanagisawa H, Davis E, Starcher B, Ouchi T, Yanagisawa M, Richardson J et al (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415(6868):168–171CrossRefPubMedGoogle Scholar
  20. 20.
    Loeys B, Van Maldergem L, Mortier G, Coucke P, Gerniers S, Naeyaert J et al (2002) Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11(8):2113–2118CrossRefPubMedGoogle Scholar
  21. 21.
    Schultz DW, Klein ML, Humpert AJ, Luzier CW, Persun V, Schain M et al (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12(24):3315–3323CrossRefPubMedGoogle Scholar
  22. 22.
    Schultz DW, Weleber RG, Lawrence G, Barral S, Majewski J, Acott TS et al (2005) HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective. Ophthalmic Genet 26(2):101–105CrossRefPubMedGoogle Scholar
  23. 23.
    Mullins RF, Hageman GS (1999) Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Hystochem Cytochem 47(12):1533–1540CrossRefGoogle Scholar
  24. 24.
    Sohn EH, Wang K, Thompson S, Riker MJ, Hoffmann JM, Stone EM et al (2014) Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration. Retina 35(1):48–57CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Murat Kucukevcilioglu
    • 1
  • Chetankumar B. Patel
    • 2
  • Edwin M. Stone
    • 3
  • Stephen R. Russell
    • 3
  1. 1.Department of OphthalmologyGulhane Military Medical SchoolEtlikTurkey
  2. 2.Greater Potomac RetinaFrederickUSA
  3. 3.Department of Ophthalmology and Visual Sciences, Stephen A. Wynn Institute for Vision Research, Carver College of MedicineThe University of IowaIowa CityUSA

Personalised recommendations